Legal Barriers in Accessing Opioid Medicines: Results of the ATOME Quick Scan of National Legislation of Eastern European Countries
Abstract Context Overregulation of controlled medicines is one of the factors contributing to limited access to opioid medicines. Objectives The purpose of this study was to identify legal barriers to access to opioid medicines in 12 Eastern European countries participating in the Access to Opioid M...
Gespeichert in:
Veröffentlicht in: | Journal of pain and symptom management 2014-12, Vol.48 (6), p.1135-1144 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1144 |
---|---|
container_issue | 6 |
container_start_page | 1135 |
container_title | Journal of pain and symptom management |
container_volume | 48 |
creator | Vranken, Marjolein J.M., PharmD, LLM Mantel-Teeuwisse, Aukje K., PharmD, PhD Jünger, Saskia, Dr rer medic Radbruch, Lukas, MD Lisman, John, PharmD, LLM Scholten, Willem, PharmD, MPA Payne, Sheila, BA (Hons), RN, DipN, PhD, Cpsychol Lynch, Tom, PhD Schutjens, Marie-Hélène D.B., LLM, PhD |
description | Abstract Context Overregulation of controlled medicines is one of the factors contributing to limited access to opioid medicines. Objectives The purpose of this study was to identify legal barriers to access to opioid medicines in 12 Eastern European countries participating in the Access to Opioid Medication in Europa project, using a quick scan method. Methods A quick scan method to identify legal barriers was developed focusing on eight different categories of barriers. Key experts in 12 European countries were requested to send relevant legislation. Legislation was quick scanned using World Health Organization guidelines. Overly restrictive provisions and provisions that contain stigmatizing language and incorrect definitions were identified. The selected provisions were scored into two categories: 1) barrier and 2) uncertain, and reviewed by two authors. A barrier was recorded if both authors agreed the selected provision to be a barrier (Category 1). Results National legislation was obtained from 11 of 12 countries. All 11 countries showed legal barriers in the areas of prescribing (most frequently observed barrier). Ten countries showed barriers in the areas of dispensing and showed stigmatizing language and incorrect use of definitions in their legislation. Most barriers were identified in the legislation of Bulgaria, Greece, Lithuania, Serbia, and Slovenia. The Cypriot legislation showed the fewest total number of barriers. Conclusion The selected countries have in common as main barriers prescribing and dispensing restrictions, the use of stigmatizing language, and incorrect use of definitions. The practical impact of these barriers identified using a quick scan method needs to be validated by other means. |
doi_str_mv | 10.1016/j.jpainsymman.2014.02.013 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1634722676</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0885392414002206</els_id><sourcerecordid>1634722676</sourcerecordid><originalsourceid>FETCH-LOGICAL-c583t-3c8bec257b1705e025953fbbdcf6486edf1af95cb12bcfa90bc40306adef09ea3</originalsourceid><addsrcrecordid>eNqNkk2P0zAQhiMEYsvCX0DmgMQlYWznkwNSqbqA1KWCXc6W40wWd1Mn60mQet4_jkPLhzhxsjx63nfseSeKXnBIOPD89S7ZDdo6Ouz32iUCeJqASIDLB9GCl4WM84zLh9ECyjKLZSXSs-gJ0Q4AMpnLx9GZSIsSeJkuovsN3uiOvdPeW_TErGNLY5DIuhu2HWxvG3aJjTXWIb1hX5CmbiTWt2z8hmx5vb1cs8-TNbfsymg31z_p0fYueAZnS93P21xfaxrRO7aefD9gYFf95MbQlZ5Gj1rdET47nefR14v19epDvNm-_7habmKTlXKMpSlrNCIral5AhiCyKpNtXTemzdMyx6bluq0yU3NRm1ZXUJsUJOS6wRYq1PI8enX0HXx_NyGNam_JYNdph_1EiucyLYTIizyg1RE1vify2KrB2732B8VBzRmonforAzVnoECokEHQPj-1meo9Nr-Vv4YegJcnQJPRXeu1M5b-cBVkoipE4FZHDsNQvod4FBmLzoQ4PJpRNb39r-e8_cfFdNbZ0PgWD0i7fvIhrfB7RUGgrualmXeGpwBCQC5_AJhNwa0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1634722676</pqid></control><display><type>article</type><title>Legal Barriers in Accessing Opioid Medicines: Results of the ATOME Quick Scan of National Legislation of Eastern European Countries</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Vranken, Marjolein J.M., PharmD, LLM ; Mantel-Teeuwisse, Aukje K., PharmD, PhD ; Jünger, Saskia, Dr rer medic ; Radbruch, Lukas, MD ; Lisman, John, PharmD, LLM ; Scholten, Willem, PharmD, MPA ; Payne, Sheila, BA (Hons), RN, DipN, PhD, Cpsychol ; Lynch, Tom, PhD ; Schutjens, Marie-Hélène D.B., LLM, PhD</creator><creatorcontrib>Vranken, Marjolein J.M., PharmD, LLM ; Mantel-Teeuwisse, Aukje K., PharmD, PhD ; Jünger, Saskia, Dr rer medic ; Radbruch, Lukas, MD ; Lisman, John, PharmD, LLM ; Scholten, Willem, PharmD, MPA ; Payne, Sheila, BA (Hons), RN, DipN, PhD, Cpsychol ; Lynch, Tom, PhD ; Schutjens, Marie-Hélène D.B., LLM, PhD</creatorcontrib><description>Abstract Context Overregulation of controlled medicines is one of the factors contributing to limited access to opioid medicines. Objectives The purpose of this study was to identify legal barriers to access to opioid medicines in 12 Eastern European countries participating in the Access to Opioid Medication in Europa project, using a quick scan method. Methods A quick scan method to identify legal barriers was developed focusing on eight different categories of barriers. Key experts in 12 European countries were requested to send relevant legislation. Legislation was quick scanned using World Health Organization guidelines. Overly restrictive provisions and provisions that contain stigmatizing language and incorrect definitions were identified. The selected provisions were scored into two categories: 1) barrier and 2) uncertain, and reviewed by two authors. A barrier was recorded if both authors agreed the selected provision to be a barrier (Category 1). Results National legislation was obtained from 11 of 12 countries. All 11 countries showed legal barriers in the areas of prescribing (most frequently observed barrier). Ten countries showed barriers in the areas of dispensing and showed stigmatizing language and incorrect use of definitions in their legislation. Most barriers were identified in the legislation of Bulgaria, Greece, Lithuania, Serbia, and Slovenia. The Cypriot legislation showed the fewest total number of barriers. Conclusion The selected countries have in common as main barriers prescribing and dispensing restrictions, the use of stigmatizing language, and incorrect use of definitions. The practical impact of these barriers identified using a quick scan method needs to be validated by other means.</description><identifier>ISSN: 0885-3924</identifier><identifier>EISSN: 1873-6513</identifier><identifier>DOI: 10.1016/j.jpainsymman.2014.02.013</identifier><identifier>PMID: 24780184</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>access ; Analgesics ; Analgesics, Opioid - therapeutic use ; Anesthesia & Perioperative Care ; ATOME ; barriers ; Biological and medical sciences ; Drug and Narcotic Control - legislation & jurisprudence ; Europe ; harm reduction ; Health Policy - legislation & jurisprudence ; Humans ; legislation ; Medical sciences ; medicines ; morphine ; Neuropharmacology ; Opioids ; Pain Medicine ; pain treatment ; palliative care ; Palliative Care - legislation & jurisprudence ; Pharmacology. Drug treatments ; regulations</subject><ispartof>Journal of pain and symptom management, 2014-12, Vol.48 (6), p.1135-1144</ispartof><rights>American Academy of Hospice and Palliative Medicine</rights><rights>2014 American Academy of Hospice and Palliative Medicine</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2014 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c583t-3c8bec257b1705e025953fbbdcf6486edf1af95cb12bcfa90bc40306adef09ea3</citedby><cites>FETCH-LOGICAL-c583t-3c8bec257b1705e025953fbbdcf6486edf1af95cb12bcfa90bc40306adef09ea3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jpainsymman.2014.02.013$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=29052972$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24780184$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vranken, Marjolein J.M., PharmD, LLM</creatorcontrib><creatorcontrib>Mantel-Teeuwisse, Aukje K., PharmD, PhD</creatorcontrib><creatorcontrib>Jünger, Saskia, Dr rer medic</creatorcontrib><creatorcontrib>Radbruch, Lukas, MD</creatorcontrib><creatorcontrib>Lisman, John, PharmD, LLM</creatorcontrib><creatorcontrib>Scholten, Willem, PharmD, MPA</creatorcontrib><creatorcontrib>Payne, Sheila, BA (Hons), RN, DipN, PhD, Cpsychol</creatorcontrib><creatorcontrib>Lynch, Tom, PhD</creatorcontrib><creatorcontrib>Schutjens, Marie-Hélène D.B., LLM, PhD</creatorcontrib><title>Legal Barriers in Accessing Opioid Medicines: Results of the ATOME Quick Scan of National Legislation of Eastern European Countries</title><title>Journal of pain and symptom management</title><addtitle>J Pain Symptom Manage</addtitle><description>Abstract Context Overregulation of controlled medicines is one of the factors contributing to limited access to opioid medicines. Objectives The purpose of this study was to identify legal barriers to access to opioid medicines in 12 Eastern European countries participating in the Access to Opioid Medication in Europa project, using a quick scan method. Methods A quick scan method to identify legal barriers was developed focusing on eight different categories of barriers. Key experts in 12 European countries were requested to send relevant legislation. Legislation was quick scanned using World Health Organization guidelines. Overly restrictive provisions and provisions that contain stigmatizing language and incorrect definitions were identified. The selected provisions were scored into two categories: 1) barrier and 2) uncertain, and reviewed by two authors. A barrier was recorded if both authors agreed the selected provision to be a barrier (Category 1). Results National legislation was obtained from 11 of 12 countries. All 11 countries showed legal barriers in the areas of prescribing (most frequently observed barrier). Ten countries showed barriers in the areas of dispensing and showed stigmatizing language and incorrect use of definitions in their legislation. Most barriers were identified in the legislation of Bulgaria, Greece, Lithuania, Serbia, and Slovenia. The Cypriot legislation showed the fewest total number of barriers. Conclusion The selected countries have in common as main barriers prescribing and dispensing restrictions, the use of stigmatizing language, and incorrect use of definitions. The practical impact of these barriers identified using a quick scan method needs to be validated by other means.</description><subject>access</subject><subject>Analgesics</subject><subject>Analgesics, Opioid - therapeutic use</subject><subject>Anesthesia & Perioperative Care</subject><subject>ATOME</subject><subject>barriers</subject><subject>Biological and medical sciences</subject><subject>Drug and Narcotic Control - legislation & jurisprudence</subject><subject>Europe</subject><subject>harm reduction</subject><subject>Health Policy - legislation & jurisprudence</subject><subject>Humans</subject><subject>legislation</subject><subject>Medical sciences</subject><subject>medicines</subject><subject>morphine</subject><subject>Neuropharmacology</subject><subject>Opioids</subject><subject>Pain Medicine</subject><subject>pain treatment</subject><subject>palliative care</subject><subject>Palliative Care - legislation & jurisprudence</subject><subject>Pharmacology. Drug treatments</subject><subject>regulations</subject><issn>0885-3924</issn><issn>1873-6513</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkk2P0zAQhiMEYsvCX0DmgMQlYWznkwNSqbqA1KWCXc6W40wWd1Mn60mQet4_jkPLhzhxsjx63nfseSeKXnBIOPD89S7ZDdo6Ouz32iUCeJqASIDLB9GCl4WM84zLh9ECyjKLZSXSs-gJ0Q4AMpnLx9GZSIsSeJkuovsN3uiOvdPeW_TErGNLY5DIuhu2HWxvG3aJjTXWIb1hX5CmbiTWt2z8hmx5vb1cs8-TNbfsymg31z_p0fYueAZnS93P21xfaxrRO7aefD9gYFf95MbQlZ5Gj1rdET47nefR14v19epDvNm-_7habmKTlXKMpSlrNCIral5AhiCyKpNtXTemzdMyx6bluq0yU3NRm1ZXUJsUJOS6wRYq1PI8enX0HXx_NyGNam_JYNdph_1EiucyLYTIizyg1RE1vify2KrB2732B8VBzRmonforAzVnoECokEHQPj-1meo9Nr-Vv4YegJcnQJPRXeu1M5b-cBVkoipE4FZHDsNQvod4FBmLzoQ4PJpRNb39r-e8_cfFdNbZ0PgWD0i7fvIhrfB7RUGgrualmXeGpwBCQC5_AJhNwa0</recordid><startdate>20141201</startdate><enddate>20141201</enddate><creator>Vranken, Marjolein J.M., PharmD, LLM</creator><creator>Mantel-Teeuwisse, Aukje K., PharmD, PhD</creator><creator>Jünger, Saskia, Dr rer medic</creator><creator>Radbruch, Lukas, MD</creator><creator>Lisman, John, PharmD, LLM</creator><creator>Scholten, Willem, PharmD, MPA</creator><creator>Payne, Sheila, BA (Hons), RN, DipN, PhD, Cpsychol</creator><creator>Lynch, Tom, PhD</creator><creator>Schutjens, Marie-Hélène D.B., LLM, PhD</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20141201</creationdate><title>Legal Barriers in Accessing Opioid Medicines: Results of the ATOME Quick Scan of National Legislation of Eastern European Countries</title><author>Vranken, Marjolein J.M., PharmD, LLM ; Mantel-Teeuwisse, Aukje K., PharmD, PhD ; Jünger, Saskia, Dr rer medic ; Radbruch, Lukas, MD ; Lisman, John, PharmD, LLM ; Scholten, Willem, PharmD, MPA ; Payne, Sheila, BA (Hons), RN, DipN, PhD, Cpsychol ; Lynch, Tom, PhD ; Schutjens, Marie-Hélène D.B., LLM, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c583t-3c8bec257b1705e025953fbbdcf6486edf1af95cb12bcfa90bc40306adef09ea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>access</topic><topic>Analgesics</topic><topic>Analgesics, Opioid - therapeutic use</topic><topic>Anesthesia & Perioperative Care</topic><topic>ATOME</topic><topic>barriers</topic><topic>Biological and medical sciences</topic><topic>Drug and Narcotic Control - legislation & jurisprudence</topic><topic>Europe</topic><topic>harm reduction</topic><topic>Health Policy - legislation & jurisprudence</topic><topic>Humans</topic><topic>legislation</topic><topic>Medical sciences</topic><topic>medicines</topic><topic>morphine</topic><topic>Neuropharmacology</topic><topic>Opioids</topic><topic>Pain Medicine</topic><topic>pain treatment</topic><topic>palliative care</topic><topic>Palliative Care - legislation & jurisprudence</topic><topic>Pharmacology. Drug treatments</topic><topic>regulations</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vranken, Marjolein J.M., PharmD, LLM</creatorcontrib><creatorcontrib>Mantel-Teeuwisse, Aukje K., PharmD, PhD</creatorcontrib><creatorcontrib>Jünger, Saskia, Dr rer medic</creatorcontrib><creatorcontrib>Radbruch, Lukas, MD</creatorcontrib><creatorcontrib>Lisman, John, PharmD, LLM</creatorcontrib><creatorcontrib>Scholten, Willem, PharmD, MPA</creatorcontrib><creatorcontrib>Payne, Sheila, BA (Hons), RN, DipN, PhD, Cpsychol</creatorcontrib><creatorcontrib>Lynch, Tom, PhD</creatorcontrib><creatorcontrib>Schutjens, Marie-Hélène D.B., LLM, PhD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pain and symptom management</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vranken, Marjolein J.M., PharmD, LLM</au><au>Mantel-Teeuwisse, Aukje K., PharmD, PhD</au><au>Jünger, Saskia, Dr rer medic</au><au>Radbruch, Lukas, MD</au><au>Lisman, John, PharmD, LLM</au><au>Scholten, Willem, PharmD, MPA</au><au>Payne, Sheila, BA (Hons), RN, DipN, PhD, Cpsychol</au><au>Lynch, Tom, PhD</au><au>Schutjens, Marie-Hélène D.B., LLM, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Legal Barriers in Accessing Opioid Medicines: Results of the ATOME Quick Scan of National Legislation of Eastern European Countries</atitle><jtitle>Journal of pain and symptom management</jtitle><addtitle>J Pain Symptom Manage</addtitle><date>2014-12-01</date><risdate>2014</risdate><volume>48</volume><issue>6</issue><spage>1135</spage><epage>1144</epage><pages>1135-1144</pages><issn>0885-3924</issn><eissn>1873-6513</eissn><abstract>Abstract Context Overregulation of controlled medicines is one of the factors contributing to limited access to opioid medicines. Objectives The purpose of this study was to identify legal barriers to access to opioid medicines in 12 Eastern European countries participating in the Access to Opioid Medication in Europa project, using a quick scan method. Methods A quick scan method to identify legal barriers was developed focusing on eight different categories of barriers. Key experts in 12 European countries were requested to send relevant legislation. Legislation was quick scanned using World Health Organization guidelines. Overly restrictive provisions and provisions that contain stigmatizing language and incorrect definitions were identified. The selected provisions were scored into two categories: 1) barrier and 2) uncertain, and reviewed by two authors. A barrier was recorded if both authors agreed the selected provision to be a barrier (Category 1). Results National legislation was obtained from 11 of 12 countries. All 11 countries showed legal barriers in the areas of prescribing (most frequently observed barrier). Ten countries showed barriers in the areas of dispensing and showed stigmatizing language and incorrect use of definitions in their legislation. Most barriers were identified in the legislation of Bulgaria, Greece, Lithuania, Serbia, and Slovenia. The Cypriot legislation showed the fewest total number of barriers. Conclusion The selected countries have in common as main barriers prescribing and dispensing restrictions, the use of stigmatizing language, and incorrect use of definitions. The practical impact of these barriers identified using a quick scan method needs to be validated by other means.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>24780184</pmid><doi>10.1016/j.jpainsymman.2014.02.013</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0885-3924 |
ispartof | Journal of pain and symptom management, 2014-12, Vol.48 (6), p.1135-1144 |
issn | 0885-3924 1873-6513 |
language | eng |
recordid | cdi_proquest_miscellaneous_1634722676 |
source | MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | access Analgesics Analgesics, Opioid - therapeutic use Anesthesia & Perioperative Care ATOME barriers Biological and medical sciences Drug and Narcotic Control - legislation & jurisprudence Europe harm reduction Health Policy - legislation & jurisprudence Humans legislation Medical sciences medicines morphine Neuropharmacology Opioids Pain Medicine pain treatment palliative care Palliative Care - legislation & jurisprudence Pharmacology. Drug treatments regulations |
title | Legal Barriers in Accessing Opioid Medicines: Results of the ATOME Quick Scan of National Legislation of Eastern European Countries |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T08%3A41%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Legal%20Barriers%20in%20Accessing%20Opioid%20Medicines:%20Results%20of%20the%20ATOME%20Quick%20Scan%20of%20National%20Legislation%20of%20Eastern%20European%20Countries&rft.jtitle=Journal%20of%20pain%20and%20symptom%20management&rft.au=Vranken,%20Marjolein%20J.M.,%20PharmD,%20LLM&rft.date=2014-12-01&rft.volume=48&rft.issue=6&rft.spage=1135&rft.epage=1144&rft.pages=1135-1144&rft.issn=0885-3924&rft.eissn=1873-6513&rft_id=info:doi/10.1016/j.jpainsymman.2014.02.013&rft_dat=%3Cproquest_cross%3E1634722676%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1634722676&rft_id=info:pmid/24780184&rft_els_id=S0885392414002206&rfr_iscdi=true |